Fetal Grafting for Parkinson's Disease: Expression of Immune Markers in Two Patients with Functional Fetal Nigral Implants
In a number of centers throughout the world, fetal nigral transplantation is being performed for the treatment of Parkinson's disease (PD). Clinical results have been inconsistent. One parameter that differs among transplant studies is the degree and manner by which patients are immunosuppresse...
Main Authors: | Jeffrey H. Kordower, Scot Styren, Martha Clarke, Stephen T. Dekosky, C. Warren Olanow, Thomas B. Freeman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
1997-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/096368979700600304 |
Similar Items
-
Dopaminergic Reinnervation of the Globus Pallidus by Fetal Nigral Grafts in the Rodent Model of Parkinson's Disease
by: L. E. Bartlett, et al.
Published: (2005-02-01) -
The Influence of Donor Age on the Survival of Solid and Suspension Intraparenchymal Human Embryonic Nigral Grafts
by: Thomas B. Freeman, et al.
Published: (1995-01-01) -
Improving nigral grafts in a model of Parkinson's disease
by: Sinclair, Simon Rupert
Published: (1998) -
Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
by: Yaping Chu, et al.
Published: (2009-09-01) -
α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2011-01-01)